MedWire News - Psoriasis - Adalimumab effective following an unsatisfactory etanercept response
Links shared publicly online about this topic.
- 1,113total visits
MedWire News - Psoriasis - Adalimumab effective following an unsatisfactory etanercept response
MedWire News Adalimumab is an effective treatment option for patients with plaque psoriasis who have not shown an adequate response or have lost their response to etanercept after a dose decrease, say researchers. MedWire News
View full resource at medwire-news.md
Tags: Psoriasis, Crohn's Disease Medication, Rheumatoid Arthritis Medication, Enbrel, Humira, News
Most Recently Shared on June 6, 2010 at 6:36 pm By:
Adalimumab effective following an unsatisfactory etanercept response: Adalimumab is an effective treatment option ... http://bit.ly/dionHM
Advertisement
